Alnylam Pharmaceuticals, Inc. (ALNY)
355.49
-3.78
(-1.05%)
USD |
NASDAQ |
Jan 20, 16:00
355.49
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 46.97B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 34.87B |
| Pfizer Inc. | 145.10B |
| Biogen, Inc. | 24.24B |
| Bristol Myers Squibb Co. | 110.40B |
| Vertex Pharmaceuticals, Inc. | 112.18B |
Market Cap Related Metrics
| PE Ratio | 1478.13 |
| PS Ratio | 14.58 |
| Price to Book Value | 200.80 |
| Price to Free Cash Flow | 211.49 |
| Price | 355.49 |
| Earnings Yield | 0.07% |
| Operating PE Ratio | 176.86 |
| Normalized PE Ratio | 229.33 |